Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Safe Supply Announces Signing of Definitive Agreement to Acquire Drug Lab 118 (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Verisante Technology Inc. V.VRS


Primary Symbol: V.VER.H

Healthcare
Verisante Technology Inc is a Canada based medical device company. It is engaged in commercializing medical systems for the early detection of cancer. The products of the company are Verisante Aura which is for skin cancer detection and Verisante Core which is for lung, colon and cervical cancer detection. It utilizes a cancer detection platform while the operating software and probe technology. The group generates revenue from the sale and renting of its medical devices.


TSXV:VER.H - Post by User

Verisante Technology Inc.
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(7)
•••
Post by bozamanon Jun 15, 2022 8:41am
210 Views
Post# 34757481

Back to the gravel

Back to the gravelVery well said Pandora, To do what?
I lost a lot of money with this 'company' beleiving the promises of Thomas Braun. Ask yourself a simple question: Do you really think dermatologist are ready to pay over 50,000$ for verisante's Aura to test skin cancer? Here in the province of Quebec, you can't even get an appointment with a  dermatologist for a skin problem but if you want to have a face lift or botox or any rejuvanating treatments,dermatologists will see you in a blink of an eye; they make a fortune for rejuvanating treatments, so why bother monituring skin cancer.Dermatologists are interested in only one thing: making $$$$$$$.
Have a nice day.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities